Lv4
404 积分 2021-05-14 加入
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
1天前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
1天前
已完结
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression
1个月前
已完结
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
1个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
1个月前
已完结
Antibody–drug conjugates come of age in oncology
1个月前
已完结
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
1个月前
已完结
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
1个月前
已完结
Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival, overall survival, and hypersensitivity reactions in real-world patients
2个月前
已关闭
Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation
2个月前
已完结
皖公网安备34019202002308
